DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Amdoxovir is an investigational drug.
There have been 5 clinical trials for Amdoxovir. The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Virus Diseases. The leading clinical trial sponsors are RFS Pharma, LLC, National Institute of Allergy and Infectious Diseases (NIAID), and [disabled in preview].
Recent Clinical Trials for Amdoxovir
|A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects||RFS Pharma, LLC||Phase 2|
|A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.||RFS Pharma, LLC||Phase 2|
|Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV||RFS Pharma, LLC||Phase 1/Phase 2|